ENST00000342183.9:c.77_79delGCG

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP3BP6_Very_Strong

The ENST00000342183.9(NRXN1):​c.77_79delGCG​(p.Gly26del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000722 in 1,354,980 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G26G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00080 ( 0 hom. )

Consequence

NRXN1
ENST00000342183.9 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 3.96

Publications

0 publications found
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]
NRXN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • chromosome 2p16.3 deletion syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Pitt-Hopkins-like syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autism
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP3
Nonframeshift variant in repetitive region in ENST00000342183.9
BP6
Variant 2-50346870-GCGC-G is Benign according to our data. Variant chr2-50346870-GCGC-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 588566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NRXN1NM_001330078.2 linkc.3365-109903_3365-109901delGCG intron_variant Intron 17 of 22 ENST00000401669.7 NP_001317007.1 E7ERL8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NRXN1ENST00000401669.7 linkc.3365-109903_3365-109901delGCG intron_variant Intron 17 of 22 5 NM_001330078.2 ENSP00000385017.2 E7ERL8

Frequencies

GnomAD3 genomes
AF:
0.0000998
AC:
15
AN:
150364
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000662
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000589
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000890
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000907
AC:
68
AN:
74950
AF XY:
0.000769
show subpopulations
Gnomad AFR exome
AF:
0.00102
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.000606
Gnomad EAS exome
AF:
0.00140
Gnomad FIN exome
AF:
0.00219
Gnomad NFE exome
AF:
0.000609
Gnomad OTH exome
AF:
0.00162
GnomAD4 exome
AF:
0.000799
AC:
963
AN:
1204616
Hom.:
0
AF XY:
0.000890
AC XY:
524
AN XY:
588858
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000630
AC:
16
AN:
25390
American (AMR)
AF:
0.00142
AC:
22
AN:
15450
Ashkenazi Jewish (ASJ)
AF:
0.00125
AC:
24
AN:
19172
East Asian (EAS)
AF:
0.00111
AC:
31
AN:
27834
South Asian (SAS)
AF:
0.00395
AC:
174
AN:
44032
European-Finnish (FIN)
AF:
0.00236
AC:
91
AN:
38486
Middle Eastern (MID)
AF:
0.00180
AC:
7
AN:
3898
European-Non Finnish (NFE)
AF:
0.000567
AC:
557
AN:
981590
Other (OTH)
AF:
0.000841
AC:
41
AN:
48764
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.276
Heterozygous variant carriers
0
120
240
361
481
601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000998
AC:
15
AN:
150364
Hom.:
0
Cov.:
32
AF XY:
0.0000682
AC XY:
5
AN XY:
73352
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41184
American (AMR)
AF:
0.0000662
AC:
1
AN:
15098
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3448
East Asian (EAS)
AF:
0.000589
AC:
3
AN:
5094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000890
AC:
6
AN:
67416
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Sep 16, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.0
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750165040; hg19: chr2-50574008; COSMIC: COSV58449887; COSMIC: COSV58449887; API